Literature DB >> 17257515

Medications in the treatment of borderline personality disorder 2006.

Deanna Mercer1.   

Abstract

This review covers all significant randomized controlled trials and open trials of medications for the treatment of borderline personality disorder. New developments in the effectiveness of mood stabilizers and antipsychotics are discussed. Differences were found in the effectiveness of medications based on the presence or absence of depression and significant anger symptoms. Medications continue to be recommended as adjuncts to psychotherapy. Most of the trials discussed require replication, and more trials that investigate the effectiveness of medications in combination with psychotherapy are recommended.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17257515     DOI： 10.1007/s11920-007-0010-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   8.081


  70 in total

1.  Treatment histories of borderline inpatients.

Authors:  M C Zanarini; F R Frankenburg; G S Khera; J Bleichmar
Journal:  Compr Psychiatry       Date:  2001 Mar-Apr       Impact factor: 3.735

2.  Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder.

Authors:  Elizabeth B Simpson; Shirley Yen; Ellen Costello; Karen Rosen; Ann Begin; Jacqueline Pistorello; Teri Pearlstein
Journal:  J Clin Psychiatry       Date:  2004-03       Impact factor: 4.384

3.  Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

Authors:  C Salzman; A N Wolfson; A Schatzberg; J Looper; R Henke; M Albanese; J Schwartz; E Miyawaki
Journal:  J Clin Psychopharmacol       Date:  1995-02       Impact factor: 3.153

4.  Naltrexone treatment of self-injurious thoughts and behaviors.

Authors:  S Sonne; R Rubey; K Brady; R Malcolm; T Morris
Journal:  J Nerv Ment Dis       Date:  1996-03       Impact factor: 2.254

5.  Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

Authors:  M J Bohus; G B Landwehrmeyer; C E Stiglmayr; M F Limberger; R Böhme; C G Schmahl
Journal:  J Clin Psychiatry       Date:  1999-09       Impact factor: 4.384

6.  Treatment of borderline personality disorder with risperidone.

Authors:  Paola Rocca; Livio Marchiaro; Elena Cocuzza; Filippo Bogetto
Journal:  J Clin Psychiatry       Date:  2002-03       Impact factor: 4.384

7.  A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.

Authors:  Mary C Zanarini; Frances R Frankenburg; Elizabeth A Parachini
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

8.  Venlafaxine in the treatment of borderline personality disorder.

Authors:  P J Markovitz; S C Wagner
Journal:  Psychopharmacol Bull       Date:  1995

9.  Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

Authors:  P H Soloff; A George; S Nathan; P M Schulz; J R Cornelius; J Herring; J M Perel
Journal:  J Clin Psychopharmacol       Date:  1989-08       Impact factor: 3.153

10.  Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands.

Authors:  Roel Verheul; Louise M C Van Den Bosch; Maarten W J Koeter; Maria A J De Ridder; Theo Stijnen; Wim Van Den Brink
Journal:  Br J Psychiatry       Date:  2003-02       Impact factor: 9.319
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.